Work of 2013 Nobel Prize Winners on Induced Pluripotent Stem Cells to be Presented at the 18th Congress of the European Hematology Association in Stockholm, June 13-16, 2013
05 Jun, 2013, 08:10 BST
THE HAGUE, the Netherlands, June 5, 2013 /PRNewswire/ --
This year the Scientific Working Group Session on hematopoietic stem cells will focus on the recent advance in the field of "Induced Pluripotent Stem Cells (IPSC)".
With the Scientific Working Group for Stem Cells, the 18th Congress of EHA took the opportunity to acknowledge the work of the 2013 winner of the Nobel Prize for Medicine or Physiology, Drs John B. Gurdon and Pr Shinya Yamanaka.
Human IPSCs, induced pluripotent stem cells which have been derived from somatic cells, promise to provide opportunities for cell therapies in regenerative medicine, stem cell modeling of human diseases and new tools for drug screening. The speakers will provide insights into the way of producing human IPSCs with a better efficiency. They will present recent data on the in vivo generation of patient customized cells, providing materials that could be useful for transplantation, human antibody generation, and drug screening. IPSCs can also be established from mature cytotoxic T lymphocytes, thereby allowing cloning and expansion of functional antigen-specific cytotoxic cells that might be useful in cell-based therapy of cancer. In addition, the use of IPSC technology will be presented as a tool to generate leukemic stem cells from chronic myeloid leukemia and allow in vitro therapeutic assays.
About the EHA Annual Congress
Hematology is a specialty that covers everything to do with blood: its origin in the bone marrow, diseases of blood and their treatments. The latest data on research and development within the spectrum of hematology will be presented. The Congress is aimed at health professionals in the field of hematology. The scientific topics range from stem cell physiology and development, to leukemia, lymphoma, myeloma - diagnosis and treatment; red blood cells -, white blood cells- and platelet disorders; thrombosis and bleeding disorders such as hemophilia and blood transfusion and stem cell transplantation.
Note for editor:
Press Briefing: Friday, June 14, 2013 from 08:30 - 10:00 CET in Hall C5 at the Stockholmsmässan.
Registration for members of the press is free. To receive your personal link for the online registration, please send an e-mail with your credentials to communication@ehaweb.org.
SOURCE European Hematology Association
Share this article